According to the latest HSC Common List published on October 17, 2022, the SARS-CoV-2 Antigen Rapid Test produced by Wizbiotech has been listed in HSC Common List Class A.

In the workshop of Xiamen Wiz Biotech Co., Ltd, workers dressed in neat overalls sit in front of the operating table and methodically pack test reagents for COVID-19 antigen.

As of September 26, 267 cases of COVID-19 had been confirmed in Xiamen, of which 221 had been confirmed. During the epidemic, the local government has carried out multiple rounds of citywide epidemic screening, establishing a reliable barrier for epidemic prevention and control.

iamen Wiz Biotech Co., Ltd is located in Xiamen Biopharmaceutical Port. The company takes rapid diagnosis as its entry point and focuses on gastrointestinal and digestive fields. From research and development, registration and approval, to market access, sales network......

COVID-19 has become a "global epidemic", and all countries are in urgent need of COVID-19 testing reagents. In order to effectively support the international community in tackling the global epidemic crisis,

Our company's "Novel Coronavirus Antibody Screening and Shunt Prevention and Control rapid detection system" has been approved by Xiamen Science and Technology Bureau.

In 2015, Xiamen Wiz Biotech Co., Ltd obtained high-tech enterprise certificate after the relevant government departments strict assessment. Wiz Biotech will take this opportunity to continuously carry out technological innovation and improve the technical level of the enterprise.